Publications by authors named "F Castagnetti"

Claim this Profile
N
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.
Fausto Castagnetti, Massimo Breccia, Elisabetta Abruzzese, Renato Bassan, Gianni Binotto

Leukemia· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study.
Massimo Breccia, Valentina Giai, Tiziana Rosso, Patrizia Pregno, Fausto Castagnetti

Br J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists.
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, Daniela Cilloni, Fausto Castagnetti

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility of a complex intervention, a medical tattooing nurse-led clinic after breast cancer surgery: results from the ARCADE_M mixed-methods study.
Deborah Maselli, Martina Torreggiani, Valeria Soffientini, Tiziana Livieri, Gloria Farioli, Fabio Castagnetti

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial.
Fabio Efficace, Laura Cannella, Isabella Capodanno, Rosaria Sancetta, Veronica Porcu, Fausto Castagnetti

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis